Find your path to Mark
254 people in our graph share verified history with Mark — schools, employers, funds. One of them is your warm intro.
Teresa ChanunlockedMark: together at Johnson & Johnson (2003–2004)
×9Mark: together at Johnson & Johnson
×2Mark: together at Reunion Neuroscience
About
Mark Theeuwes is Chief Operating Officer at Reunion Neuroscience and serves as a Strategic Advisor at Somnia Therapeutics. His background spans clinical and commercial execution within the pharmaceutical industry.
Executive at Reunion Neuroscience
Intro paths
→
In turn, Mark can intro founders to Reunion Neuroscience's investors below.
Experience
- Somnia TherapeuticsStrategic Advisorcurrent2023 — present
- Reunion NeuroscienceChief Operating Officercurrent2023 — present
- Pharmaceutical Services, LLCPrincipalcurrent2018 — present
- Epilepsy FoundationMember Board of Directors2022 — 2026
- Receptor Life Sciences, Inc.Member Board of Directors2021 — 2023
- Receptor Life Sciences, Inc.President and Chief Executive Officer2021 — 2023
- Engage TherapeuticsChief Operating Officer2019 — 2020
- Engage TherapeuticsVice President, External Operations2018 — 2019Summit, NJ
- Egalet CorporationVice president, Sales, Trade Relations, and Commercial Operations2016 — 2018Wayne, Pennsylvania
- Egalet CorporationVice President, Analytics2015 — 2016
- NPS PharmaceuticalsExecutive Director, Business Information and Decision Support2014 — 2015Bedminster, NJ
- ViroPharma IncorporatedDirector, Commercial Operations2012 — 2014Exton, PA
- OraPharma Inc.Director, Commercial Analytics and Operations2011 — 2012Horsham, PA
- OraPharmaSr. Manager of Sales Force Effectiveness2009 — 2011
- Johnson & JohnsonManager, Strategic Analytics2009
- Johnson & JohnsonRegion Analytics Manager2007 — 2009
- Johnson & JohnsonDistrict Manager, PriCara2003 — 2007
- Ortho-McNeil PharmaceuticalRegion Training Manager2001 — 2003
- Ortho-McNeil PharmaceuticalSales Representative2001
- ALZA CorporationSales Representative1999 — 2001
Skills & more
Business Analytics5Sales Management33Sales Operations34Direct Sales3Sales AnalyticsTraining & DevelopmentPharmaceutical Sales74Optimization2Analytics26Forecasting16Demand Forecasting2Revenue Forecasting1
+12 more
CRM softwareSalesforce.comBusiness Intelligence ToolsBusiness AnalysisNew Business DevelopmentSales CompensationProduct Life Cycle ManagementStrategic AnalysisMicrosoft OfficeMarketing SupportSales Skills TrainingLeadershipLanguages Dutch
From Mark's professional profile.
Frequently asked questions
- Who is Mark Theeuwes?
- Mark Theeuwes is Chief Operating Officer at Reunion Neuroscience and serves as a Strategic Advisor at Somnia Therapeutics. His background spans clinical and commercial execution within the pharmaceutical industry.
- Where does Mark Theeuwes work?
- Mark Theeuwes is Executive at Reunion Neuroscience.
- Where did Mark Theeuwes go to school?
- Mark Theeuwes studied at Certified Medical Representative (CMR, Business in Healthcare); University of California, Riverside (BS, Biochemistry).
Same school
Also attended University of California, Riverside77
Mellissa GraySenior Scientist, Protein Sciences at Deerfield Management CompanyDr Jonathan AvesarScientific Lead at Lever VCBrett TeeleChief Financial Officer & Partner at Unusual VenturesLina ChongInvestor at HV CapitalVanessa SmallInvestor at DigitalDx VenturesBo ZhaoDirector of Commercialization at First Bight Ventures
+ 71 more
Shared employers
Also worked at Epilepsy Foundation4
Also worked at NPS Pharmaceuticals8
Sam LeeImpact Partner at Fresco CapitalDouglas ReedGeneral Partner at Hatteras Venture PartnersDavid PiersonManaging Director at Syngenta Group VenturesVanessa WilliamsonVP, Investor Relations at Keiretsu Forum CanadaBrian O'CallaghanChief Executive Officer at Deep GenomicsDouglas ReedGeneral Partner at Hatteras
+ 2 more
Also worked at Johnson & Johnson361
Teresa ChanChief Financial Officer at Felicis VenturesKarthik ArdhanareeswaranInvestor at GV (Google Ventures)KobeFinance Director at Hummingbird VenturesMickelFinance & Risk Management at Hummingbird VenturesHal PazInvestor at Khosla VenturesNiall O'DonnellManaging Director at RiverVest Venture Partners
+ 355 more
